FIELD: medicine, dermatology. SUBSTANCE: invention relates to treatment of patients with psoriasis and involves additional administration of immunotropic preparations in the course of photochemotherapy carrying out. Administration of the latter is considered to be indicated at sensitivity index value of lymphocytes to regulatory peptides of these preparations above 1.0. The preparation with the highest value of sensitivity index is administrated. Method provides high treatment effect due to the choice of diseases phase where immune correction is useful. EFFECT: enhanced effectiveness of treatment. 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF PATIENT WITH PSORIASIS | 1995 |
|
RU2135184C1 |
| METHOD FOR DETERMINING PATHOLOGICAL PROCESS STAGE IN TESTS FOR EVALUATING FUNCTIONAL ACTIVITY OF LYMPHOCYTES | 1997 |
|
RU2175769C2 |
| METHOD OF TREATING PSORIATIC ERYTHRODERMA | 2011 |
|
RU2496498C2 |
| METHOD OF PROGNOSIS OF PSORIASIS COURSE | 1997 |
|
RU2134882C1 |
| METHOD OF TREATING PSORIASIS | 2009 |
|
RU2394575C1 |
| METHOD FOR TREATMENT OF PSORIASIS | 0 |
|
SU1674849A1 |
| METHOD OF CURE FOR ERYTHRODERMA PSORIATICUM | 2008 |
|
RU2369394C1 |
| METHOD FOR TREATMENT OF FUNGUS-LIKE MYCOSIS | 2003 |
|
RU2234921C1 |
| METHOD OF PSORIASIS TREATMENT | 1993 |
|
RU2088225C1 |
| METHOD FOR DETERMINING NECESSITY AND EFFICIENCY FOR IMMUNOCORRECTION OF IMMUNE SYSTEM T-LINK | 2000 |
|
RU2187119C2 |
